Overview

The Effect of Rifaximin on Portal Vein Thrombosis

Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of rifaximin in the treatment of portal vein thrombosis in cirrhotic patients
Phase:
N/A
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Treatments:
Rifamycins
Rifaximin